Literature DB >> 27751883

FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Sudhir Gupta1, Sudhanshu Agrawal2, Sastry Gollapudi2, Hiromi Kubagawa2.   

Abstract

IgMFcR (FcμR) are expressed on B cell and B cell subsets. Mice deficient in secreted IgM and FcμR share properties of impaired specific antibody response and autoimmunity with patient with selective IgM deficiency (SIGMD). Intravenous immunoglobulin (IGIV) regulates immune response, including modulation of IgGFc receptors. However, there are no data on the expression of FcμR in patients with SIGMD, and the effects of IGIV on FcμR. In this study, we investigated FcμR expression in naïve marginal zone (MZ), IgM memory, and class-switched memory B cells in patients with selective IgM deficiency and healthy controls. Furthermore, we examined the direct effect of IGIV on FcμR expression and on the upregulation of FcμR by TLR2 agonist (Pam3). Finally, we examined the effect of IVIG on spontaneously produced IgM and natural IgM anti-phosphorylcholine (PC) antibodies by B cells and B1 cells. FcμR expression is significantly decreased in MZ B cells in patients with SIGMD as compared to control. IGIV, at immunomodulatory concentrations, inhibited FcμR upregulation by Pam3 in MZ B cells, and IgM-depleted IGIV inhibited spontaneous secretion of natural IgM anti-PC antibodies and not total IgM by B1 cells. These data suggest that decreased FcμR expression on MZ B cells may play a role in the pathogenesis of SIGMD, and an inhibition of TLR-2-induced upregulation of FcμR by IGIV may be one of the mechanisms of its anti-inflammatory action. IGIV-induced inhibition of natural IgM antibodies may be one of the mechanisms of IGIV-induced immunoregulation. Copyright Â
© 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-phosphorylcholine IgM antibodies; FcμR; IGIV; Marginal zone B cells; Natural antibodies; TLR

Mesh:

Substances:

Year:  2016        PMID: 27751883      PMCID: PMC5812685          DOI: 10.1016/j.humimm.2016.10.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  46 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Intravenous immunoglobulin: exploiting the potential of natural antibodies.

Authors:  Srini V Kaveri
Journal:  Autoimmun Rev       Date:  2012-02-12       Impact factor: 9.754

Review 3.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

4.  Heterogeneity of locomotion in human T cell subsets.

Authors:  D M Parrott; R A Good; G J O'Neill; S Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 5.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

6.  The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Authors:  Krishanthi S Subramaniam; Kausik Datta; Eric Quintero; Catherine Manix; Matthew S Marks; Liise-Anne Pirofski
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

7.  Clinical and immunological features in IgM deficiency.

Authors:  Leman Yel; Srinivasan Ramanuja; Sudhir Gupta
Journal:  Int Arch Allergy Immunol       Date:  2009-06-04       Impact factor: 2.749

Review 8.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

9.  Ontogeny of lymphocyte subpopulations in human fetal liver.

Authors:  S Gupta; R Pahwa; R O'Reilly; R A Good; F P Siegal
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more
  3 in total

Review 1.  Selective IgM Deficiency-An Underestimated Primary Immunodeficiency.

Authors:  Sudhir Gupta; Ankmalika Gupta
Journal:  Front Immunol       Date:  2017-09-05       Impact factor: 7.561

Review 2.  Functional Roles of the IgM Fc Receptor in the Immune System.

Authors:  Hiromi Kubagawa; Kazuhito Honjo; Naganari Ohkura; Shimon Sakaguchi; Andreas Radbruch; Fritz Melchers; Peter K Jani
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

3.  An Unexpected Role for Cell Density Rather than IgM in Cell-Surface Display of the Fc Receptor for IgM on Human Lymphocytes.

Authors:  Cassandra R Woolley; Nicholas C Brinkman; Elizabeth D Cash; Swapna K Chandran; Thomas C Mitchell
Journal:  Immunohorizons       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.